Literature DB >> 8102011

Mechanisms of drug resistance in human lung cancer cells.

L A Doyle1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102011

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

1.  Identification of semaphorin E as a non-MDR drug resistance gene of human cancers.

Authors:  T Yamada; R Endo; M Gotoh; S Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

2.  Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.

Authors:  Walter Berger; Ulrike Setinek; Peter Hollaus; Thomas Zidek; Elisabeth Steiner; L Elbling; H Cantonati; Johannes Attems; Andrea Gsur; Michael Micksche
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-27       Impact factor: 4.553

3.  Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study.

Authors:  Katerina Vrzalikova; Joseph Skarda; Jiri Ehrmann; Paul G Murray; Eduard Fridman; Jury Kopolovic; Petra Knizetova; Marian Hajduch; Jiri Klein; Vitezslav Kolek; Lenka Radova; Zdenek Kolar
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-09       Impact factor: 4.553

4.  The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.

Authors:  K Nooter; G Brutel de la Riviere; M P Look; K E van Wingerden; S C Henzen-Logmans; R J Scheper; M J Flens; J G Klijn; G Stoter; J A Foekens
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  ANTITUMOR AND APOPTOTIC EFFECTS OF CUCURBITACIN A IN A-549 LUNG CARCINOMA CELLS IS MEDIATED VIA G2/M CELL CYCLE ARREST AND M-TOR/PI3K/AKT SIGNALLING PATHWAY.

Authors:  Wen-Dong Wang; Yan Liu; Yuan Su; Xian-Zhi Xiong; Dan Shang; Juan-Juan Xu; Hong-Ju Liu
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

6.  An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.

Authors:  L A Doyle; D D Ross; J V Ordonez; W Yang; Y Gao; Y Tong; C P Belani; J C Gutheil
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

7.  Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines.

Authors:  U Zangemeister-Wittke; T Schenker; G H Luedke; R A Stahel
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.